Proscia launches digital pathology software

By staff writers

April 27, 2020 -- Artificial intelligence (AI) digital pathology software firm Proscia has launched a new package for reviewing and reporting digital pathology slides.

The software, called Concentriq Dx, already has the CE Mark for use in Europe. Its release comes as the U.S. Food and Drug Administration issued new guidance on April 27 to expand the availability of remote digital pathology tools and devices.

Concentriq Dx allows pathologists to read cases remotely via any scanner and laboratory information system, and it can be integrated with Leica, 3DHISTECH, and Hamamatsu equipment, according to the firm.

FDA issues COVID-19 digital pathology device guidance
The U.S. Food and Drug Administration (FDA) has issued a guidance document regarding the use of remote digital pathology devices during the COVID-19 crisis.
Proscia touts AI pathology research results
Artificial intelligence (AI) digital pathology software firm Proscia is highlighting findings from a study published February 21 in Scientific Reports...
Proscia thinks big with Dell in digital pathology
Proscia announced a collaboration with Dell Technologies on the expanded version of its Concentriq digital pathology software platform that it said will...
Artificial intelligence takes root in pathology
Artificial intelligence -- the simulation of human intelligence processes by software -- is reaching commercial pathology labs and has begun to significantly...
Smaller labs eye digital pathology options to improve workflow
As workloads increase in laboratory medicine, some pathology labs have considered harnessing new technologies to improve workflow and efficiency. One...

Copyright © 2020

Last Updated np 4/27/2020 2:20:57 PM